Targeted regulation of ferroptosis through drugs could represent a novel approach for treating AS-depression comorbidities
The drug pipeline continues to expand exponentially, including the more than 120 GLP-1 formulations in development as of April 2024
Table of Contents Understanding the Oral GLP1 Opportunity Reframing the Market: From Weight Loss to WholePerson Outcomes Messaging that Matters: Clarity, Context, and Credibility Channel Choices in a Multiformat Environment Addressing Access, Affordability, and Health Inequities Staying Honest About Safety and Expectations Measuring Success in a Complex Therapeutic Landscape FAQs Understanding the Oral GLP1 Opportunity The arrival of oral GLP1 therapies is transforming treatment pathways
Domitrovi R, Jakovac H, Romi , Raheli D, Tadi
L-
Nature cell biology, 2023 doi: Fujimaki, K